20 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Article Searches
HAE vs. ABT: Which Stock Is the Better Value Option? https://www.zacks.com/stock/news/2252781/hae-vs-abt-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2252781 Apr 09, 2024 - HAE vs. ABT: Which Stock Is the Better Value Option?
What's in Store for Abbott Laboratories (ABT) in Q1 Earnings? https://www.zacks.com/stock/news/2254571/what-s-in-store-for-abbott-laboratories-abt-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2254571 Apr 12, 2024 - Abbott (ABT) is likely to have progressed with its initiative to commercialize several biosimilars in emerging markets.
5 stocks to watch on Wednesday: LLY, ABT and more https://seekingalpha.com/news/4090463-5-stocks-to-watch-on-wednesday-lly-abt-and-more?source=feed_sector_healthcare Apr 17, 2024 - Eli Lilly (LLY), Abbott Laboratories (ABT), Travelers (TRV), Capri (CPRI) and Tapestry (TPR) are the stocks to watch on Wednesday.
Top Research Reports for Abbott, T-Mobile & Booking https://www.zacks.com/commentary/2219543/top-research-reports-for-abbott-t-mobile-booking?cid=CS-ZC-FT-research_daily-2219543 Feb 01, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), T-Mobile US, Inc. (TMUS) Booking Holdings Inc. (BKNG).
HAE vs. ABT: Which Stock Is the Better Value Option? https://www.zacks.com/stock/news/2221954/hae-vs-abt-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2221954 Feb 06, 2024 - HAE vs. ABT: Which Stock Is the Better Value Option?
Abbott (ABT) Expands in Canada With First Eterna SCS Use https://www.zacks.com/stock/news/2245409/abbott-abt-expands-in-canada-with-first-eterna-scs-use?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2245409 Mar 25, 2024 - Abbott's (ABT) Eterna SCS system reduces pain without causing discomfort. It leverages the BurstDR stimulation technology.
Abbott (ABT) Faces Low Testing Demand, Currency Headwinds https://www.zacks.com/stock/news/2251992/abbott-abt-faces-low-testing-demand-currency-headwinds?cid=CS-ZC-FT-analyst_blog|zer_report_update-2251992 Apr 08, 2024 - Abbott's (ABT) core laboratory diagnostics business is gaining strength on the continued success of the Alinity suite of diagnostics instruments, along with a broad test menu offering.
Abbott (ABT) Rises Higher Than Market: Key Facts https://www.zacks.com/stock/news/2252958/abbott-abt-rises-higher-than-market-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2252958 Apr 09, 2024 - The latest trading day saw Abbott (ABT) settling at $112.44, representing a +1.74% change from its previous close.
Abbott (ABT) Q1 Earnings Beat Estimates, Margins Contract https://www.zacks.com/stock/news/2256957/abbott-abt-q1-earnings-beat-estimates-margins-contract?cid=CS-ZC-FT-analyst_blog|earnings_article-2256957 Apr 17, 2024 - Abbott (ABT) delivers double-digit organic sales growth in its underlying base business in the first quarter of 2024.
Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2024/04/17/abbott-laboratories-abt-q1-2024-earnings-call-tran/?source=iedfolrf0000001 Apr 17, 2024 - ABT earnings call for the period ending March 31, 2024.

Pages: 12

<Page 2